Related Experiment Video
Updated: Aug 29, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
[Genetic engineering potential and perspectives in the management of critical ischemia]
B A Konstantinov1, N P Bochkov, A V Gavrilenko
1Department of Vascular Surgery, Russian Research Center of Surgery, Russian Academy of Medical Sciences, Moscow, Russia.
Abstract:
The paper presents a new approach to management of lower limb critical ischemia which implements recent advances in molecular biology and genetic engineering technologies. A new original compound incorporating angiogenin gene was developed to activate neoangiogenesis processes after injection into living tissues. Experimental data evidence a potential efficacy of new method for complex management of critical ischemia.
Related Concept Videos
What is Genetic Engineering?
CRISPR
Ischemic Stroke ll: Pathophysiology
Gene Therapy
Pharmacogenomics: Identification of New Drug Targets

